BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26343548)

  • 1. Spreading of a Lidocaine Formulation on Microneedle-Treated Skin.
    Nayak A; Das DB; Chao TC; Starov VM
    J Pharm Sci; 2015 Dec; 104(12):4109-4116. PubMed ID: 26343548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large Size Microneedle Patch to Deliver Lidocaine through Skin.
    Kathuria H; Li H; Pan J; Lim SH; Kochhar JS; Wu C; Kang L
    Pharm Res; 2016 Nov; 33(11):2653-67. PubMed ID: 27401408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidocaine permeation from a lidocaine NaCMC/gel microgel formulation in microneedle-pierced skin: vertical (depth averaged) and horizontal permeation profiles.
    Nayak A; Short L; Das DB
    Drug Deliv Transl Res; 2015 Aug; 5(4):372-86. PubMed ID: 25895729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new paradigm for numerical simulation of microneedle-based drug delivery aided by histology of microneedle-pierced skin.
    Han T; Das DB
    J Pharm Sci; 2015 Jun; 104(6):1993-2007. PubMed ID: 25821048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration.
    McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug.
    Ma Y; Gill HS
    J Pharm Sci; 2014 Nov; 103(11):3621-3630. PubMed ID: 25213295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations.
    Caffarel-Salvador E; Tuan-Mahmood TM; McElnay JC; McCarthy HO; Mooney K; Woolfson AD; Donnelly RF
    Int J Pharm; 2015 Jul; 489(1-2):158-69. PubMed ID: 25940042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate.
    Kaur M; Ita KB; Popova IE; Parikh SJ; Bair DA
    Eur J Pharm Biopharm; 2014 Feb; 86(2):284-91. PubMed ID: 24176676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin.
    Kim M; Jung B; Park JH
    Biomaterials; 2012 Jan; 33(2):668-78. PubMed ID: 22000788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Hydrogels for Microneedle-Assisted Transdermal Delivery of Naloxone for Opioid-Induced Pruritus.
    Gao X; Brogden NK
    J Pharm Sci; 2019 Nov; 108(11):3695-3703. PubMed ID: 31476312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo evaluation of a microneedle array device for transdermal application.
    Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
    Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
    Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
    Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquid.
    Miwa Y; Hamamoto H; Ishida T
    Eur J Pharm Biopharm; 2016 May; 102():92-100. PubMed ID: 26945484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of hydrophobic peptides for skin delivery via coated microneedles.
    Zhao X; Coulman SA; Hanna SJ; Wong FS; Dayan CM; Birchall JC
    J Control Release; 2017 Nov; 265():2-13. PubMed ID: 28286315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.
    Milewski M; Brogden NK; Stinchcomb AL
    Expert Opin Drug Deliv; 2010 May; 7(5):617-29. PubMed ID: 20205604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lidocaine-loaded fish scale-nanocellulose biopolymer composite microneedles.
    Medhi P; Olatunji O; Nayak A; Uppuluri CT; Olsson RT; Nalluri BN; Das DB
    AAPS PharmSciTech; 2017 Jul; 18(5):1488-1494. PubMed ID: 28353171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
    Donnelly RF; Garland MJ; Alkilani AZ
    Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel in situ forming hydrogel microneedles for transdermal drug delivery.
    Sivaraman A; Banga AK
    Drug Deliv Transl Res; 2017 Feb; 7(1):16-26. PubMed ID: 27562294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of a Pressure-Indicating Sensor Film to Provide Feedback upon Hydrogel-Forming Microneedle Array Self-Application In Vivo.
    Vicente-Pérez EM; Quinn HL; McAlister E; O'Neill S; Hanna LA; Barry JG; Donnelly RF
    Pharm Res; 2016 Dec; 33(12):3072-3080. PubMed ID: 27633885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.